PetaGene’s mission is to make genomics data cheaper, faster and better.
Petagene has raised €3.6M across 2 funding rounds from 1 investor, most recently a Series A round in Dec 2018. Based in Cambridge, UK; founded 2015; active in Healthtech. Data as of 7 Aug 2026.
Timing: dormant vs cohort gap · momentum flat. Funding-only estimates, not predictions and not investment advice — see signals.
| Date |
|---|
| Stage |
|---|
| Amount |
|---|
| Investors |
|---|
| 2018-12-26 | Series A | €1.8M | Romulus Capital | View deal → |
| 2018-12-20 | Series A | €1.8M | Romulus Capital | View deal → |
